Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes

OBJECTIVE: To evaluate the pharmacokinetics, pharmacodynamics, and safety of a novel U500 insulin aspart formulation (AT278 U500) compared with insulin aspart (IAsp U100). RESEARCH DESIGN AND METHODS: This single-center, randomized, double-blind study was conducted in 38 men with type 1 diabetes (bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Svehlikova, Eva, Ashcroft, Nicole L., Gatschelhofer, Christina, Gerring, David, Höller, Vera, Jezek, Jan, Lackner, Bettina, Lawrence, Fiona, Pillai, Vijay, Ratzer, Maria, Urschitz, Martina, Wolf, Michael, Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090892/
https://www.ncbi.nlm.nih.gov/pubmed/36710473
http://dx.doi.org/10.2337/dc22-1054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090892/
https://www.ncbi.nlm.nih.gov/pubmed/36710473
http://dx.doi.org/10.2337/dc22-1054

Ejemplares similares